Document is current
Any future updates will be listed below
-
Authors
Sarazin, Marie https://orcid.org/0000-0002-5438-8392
Lagarde, Julien https://orcid.org/0000-0002-2018-261X
El Haddad, Inès
de Souza, Leonardo Cruz
Bellier, Bertrand
Potier, Marie-Claude
Bottlaender, Michel
Dorothée, Guillaume https://orcid.org/0000-0001-5763-3632
- License Information
-
More Information
Article History
Received: 17 July 2023
Accepted: 9 April 2024
First Online: 5 June 2024
Competing interests
: G.D. is listed as an inventor on one patent and one patent application, both on T<sub>reg</sub>-based immunomodulatory treatments in AD and other tauopathies. G.D. served on the scientific advisory board of Coya Therapeutics and received lecturer fees from Eisai. G.D. and M.S. received research support from Institut Roche. L.C.d.S. participated in the advisory board for Biogen and as speaker in symposia sponsored by Biogen. The other authors declare no competing interests.
